molecular function |
| GO:0005515 | | protein binding | | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
| GO:0046983 | | protein dimerization activity | | The formation of a protein dimer, a macromolecular structure consists of two noncovalently associated identical or nonidentical subunits. |
biological process |
| GO:0097202 | | activation of cysteine-type endopeptidase activity | | Any process that initiates the activity of the inactive enzyme cysteine-type endopeptidase. |
| GO:0006919 | | activation of cysteine-type endopeptidase activity involved in apoptotic process | | Any process that initiates the activity of the inactive enzyme cysteine-type endopeptidase in the context of an apoptotic process. |
| GO:0002218 | | activation of innate immune response | | Any process that initiates an innate immune response. Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens. Examples of this process include activation of the hypersensitive response of Arabidopsis thaliana and activation of any NOD or TLR signaling pathway in vertebrate species. |
| GO:0006954 | | inflammatory response | | The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages. |
| GO:0045087 | | innate immune response | | Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens. |
| GO:0032611 | | interleukin-1 beta production | | The appearance of interleukin-1 beta due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels. |
| GO:0044351 | | macropinocytosis | | An endocytosis process that results in the uptake of liquid material by cells from their external environment by the 'ruffling' of the cell membrane to form heterogeneously sized intracellular vesicles called macropinosomes, which can be up to 5 micrometers in size. |
| GO:0002277 | | myeloid dendritic cell activation involved in immune response | | The change in morphology and behavior of a myeloid dendritic cell resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor, leading to the initiation or perpetuation of an immune response. |
| GO:0032088 | | negative regulation of NF-kappaB transcription factor activity | | Any process that stops, prevents, or reduces the frequency, rate or extent of the activity of the transcription factor NF-kappaB. |
| GO:1900226 | | negative regulation of NLRP3 inflammasome complex assembly | | Any process that stops, prevents or reduces the frequency, rate or extent of NLRP3 inflammasome complex assembly. |
| GO:0050713 | | negative regulation of interleukin-1 beta secretion | | Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of interleukin-1 beta from a cell. |
| GO:0006469 | | negative regulation of protein kinase activity | | Any process that stops, prevents, or reduces the frequency, rate or extent of protein kinase activity. |
| GO:0009968 | | negative regulation of signal transduction | | Any process that stops, prevents, or reduces the frequency, rate or extent of signal transduction. |
| GO:0010804 | | negative regulation of tumor necrosis factor-mediated signaling pathway | | Any process that decreases the rate or extent of the tumor necrosis factor-mediated signaling pathway. The tumor necrosis factor-mediated signaling pathway is the series of molecular signals generated as a consequence of tumor necrosis factor binding to a cell surface receptor. |
| GO:0070374 | | positive regulation of ERK1 and ERK2 cascade | | Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade. |
| GO:2000406 | | positive regulation of T cell migration | | Any process that activates or increases the frequency, rate or extent of T cell migration. |
| GO:0030838 | | positive regulation of actin filament polymerization | | Any process that activates or increases the frequency, rate or extent of actin polymerization. |
| GO:0042104 | | positive regulation of activated T cell proliferation | | Any process that activates or increases the rate or extent of activated T cell proliferation. |
| GO:0002588 | | positive regulation of antigen processing and presentation of peptide antigen via MHC class II | | Any process that activates or increases the frequency, rate, or extent of antigen processing and presentation of peptide antigen via MHC class II. |
| GO:0090197 | | positive regulation of chemokine secretion | | Any process that increases the rate, frequency or extent of chemokine secretion, the regulated release of chemokines from a cell. |
| GO:0002230 | | positive regulation of defense response to virus by host | | Any host process that results in the promotion of antiviral immune response mechanisms, thereby limiting viral replication. |
| GO:0032729 | | positive regulation of interferon-gamma production | | Any process that activates or increases the frequency, rate, or extent of interferon-gamma production. Interferon-gamma is also known as type II interferon. |
| GO:0050718 | | positive regulation of interleukin-1 beta secretion | | Any process that activates or increases the frequency, rate or extent of the regulated release of interleukin-1 beta from a cell. |
| GO:0032755 | | positive regulation of interleukin-6 production | | Any process that activates or increases the frequency, rate, or extent of interleukin-6 production. |
| GO:0050766 | | positive regulation of phagocytosis | | Any process that activates or increases the frequency, rate or extent of phagocytosis. |
| GO:0043087 | | regulation of GTPase activity | | Any process that modulates the rate of GTP hydrolysis by a GTPase. |
| GO:0042981 | | regulation of apoptotic process | | Any process that modulates the occurrence or rate of cell death by apoptotic process. |
| GO:0010506 | | regulation of autophagy | | Any process that modulates the frequency, rate or extent of autophagy. Autophagy is the process in which cells digest parts of their own cytoplasm. |
| GO:0043281 | | regulation of cysteine-type endopeptidase activity involved in apoptotic process | | Any process that modulates the activity of a cysteine-type endopeptidase involved in apoptosis. |
| GO:0050727 | | regulation of inflammatory response | | Any process that modulates the frequency, rate or extent of the inflammatory response, the immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. |
| GO:0031647 | | regulation of protein stability | | Any process that affects the structure and integrity of a protein, altering the likelihood of its degradation or aggregation. |
| GO:0009617 | | response to bacterium | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a bacterium. |
| GO:0033209 | | tumor necrosis factor-mediated signaling pathway | | A series of molecular signals initiated by the binding of a tumor necrosis factor to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription. |
cellular component |
| GO:0008385 | | IkappaB kinase complex | | A trimeric protein complex that phosphorylates inhibitory-kappaB (I-kappaB) proteins. The complex is composed of two kinase subunits (alpha and beta) and a regulatory gamma subunit (also called NEMO). In a resting state, NF-kappaB dimers are bound to inhibitory IKB proteins, sequestering NF-kappaB in the cytoplasm. Phosphorylation of I-kappaB targets I-kappaB for ubiquitination and proteasomal degradation, thus releasing the NF-kappaB dimers, which can translocate to the nucleus to bind DNA and regulate transcription. |
| GO:0005737 | | cytoplasm | | All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| GO:0005829 | | cytosol | | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
| GO:0005576 | | extracellular region | | The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite. |
| GO:0005634 | | nucleus | | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |